Becton, Dickinson agrees to settle a patent infringement lawsuit with Hologic’s Gen-Probe over sexually transmitted disease diagnostics. Becton Dickinson & Co. (NYSE:BDX) said it’s settled a patent infringement lawsuit against Hologic’s (NSDQ:HOLX) Gen-Probe subsidiary, a month after a federal judge ruled that BD violates a trio of the Gen-Probe patents. Gen-Probe sued BD in 2009, alleging that BD’s Viper XTR and BDMax diagnostics infringe a clutch of its patents covering automated nucleic acid testing. Hologic inherited the lawsuit when it bought Gen-Probe for $3.7 billion earlier this year.
